{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:16:29Z","timestamp":1784891789126,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ijcard.2016.04.001","type":"journal-article","created":{"date-parts":[[2016,4,11]],"date-time":"2016-04-11T18:16:06Z","timestamp":1460398566000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction"],"prefix":"10.1016","volume":"215","author":[{"given":"Paolo G.","family":"Camici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Gloekler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard I.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Skalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"Tagliamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panos","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Heusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.04.001_bb0005","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.eurheartj.a014668","article-title":"Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group","volume":"17","author":"Dargie","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0015","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","article-title":"Coronary microvascular dysfunction: an update","volume":"35","author":"Crea","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0020","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0025","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0030","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4month, randomized, placebo-controlled trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0040","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","article-title":"Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction","volume":"29","author":"Heusch","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0045","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1111\/bph.13220","article-title":"Pleiotropic, heart rate-independent cardioprotection by ivabradine","volume":"172","author":"Kleinbongard","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/01.RES.50.6.775","article-title":"Phasic coronary blood flow velocity in intramural and epicardial coronary arteries","volume":"50","author":"Chilian","year":"1982","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0055","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/01.RES.41.5.648","article-title":"Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog","volume":"41","author":"Bache","year":"1977","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0060","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1161\/01.RES.30.1.67","article-title":"Experimental subendocardial ischemia in dogs with normal coronary arteries","volume":"30","author":"Buckberg","year":"1972","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0065","doi-asserted-by":"crossref","first-page":"e000285","DOI":"10.1161\/JAHA.113.000285","article-title":"The myocardial oxygen supply:demand index revisited","volume":"3","author":"Hoffman","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0070","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","article-title":"Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents","volume":"153","author":"Heusch","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0075","doi-asserted-by":"crossref","first-page":"H676","DOI":"10.1152\/ajpheart.00564.2002","article-title":"Contributions of heart rate and contractility to myocardial oxygen balance during exercise","volume":"284","author":"Colin","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.115.06091","article-title":"Impact of ivabradine on central aortic blood pressure and myocardial perfusion in patients with stable coronary artery disease","volume":"66","author":"Dillinger","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","article-title":"Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice","volume":"154","author":"Drouin","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0090","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","article-title":"Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice","volume":"117","author":"Custodis","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s12325-015-0253-x","article-title":"Effect of ivabradine on endothelial function in patients with stable angina pectoris: assessment with the Endo-PAT 2000 device","volume":"32","author":"Jedlickova","year":"2015","journal-title":"Adv Ther"},{"issue":"Suppl.1","key":"10.1016\/j.ijcard.2016.04.001_bb0100","first-page":"1105","article-title":"P6291: heart rate reduction by ivabradine for improvement of endothelial function in patients with coronary artery disease: the randomized open-label RIVENDEL study","volume":"36","author":"Mangiacapra","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.RES.60.5.738","article-title":"Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs","volume":"60","author":"Guth","year":"1987","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1161\/01.RES.62.3.436","article-title":"Intracoronary alpha 2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise","volume":"62","author":"Seitelberger","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0115","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/01.CIR.99.16.2090","article-title":"Augmented alpha-adrenergic constriction of atherosclerotic human coronary arteries","volume":"99","author":"Baumgart","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0022-3565(25)12114-9","article-title":"Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs","volume":"275","author":"Simon","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0125","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.CIR.101.6.689","article-title":"Alpha-adrenergic coronary vasoconstriction and myocardial ischemia in humans","volume":"101","author":"Heusch","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0130","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.CIR.98.1.40","article-title":"Improved assessment of coronary stenosis severity using the relative flow velocity reserve","volume":"98","author":"Baumgart","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-009-0074-7","article-title":"Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve","volume":"105","author":"Heusch","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0140","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","article-title":"Coronary microvascular dysfunction: mechanisms and functional assessment","volume":"12","author":"Camici","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2010.11.035","article-title":"Ivabradine improves coronary flow reserve in patients with stable coronary artery disease","volume":"215","author":"Skalidis","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0150","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12325-015-0237-x","article-title":"Ivabradine and bisoprolol on doppler-derived coronary flow velocity reserve in patients with stable coronary artery disease: beyond the heart rate","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Adv Ther"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0155","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.yjmcc.2011.09.010","article-title":"The coronary collateral circulation: genetic and environmental determinants in experimental models and humans","volume":"52","author":"Teunissen","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/CIRCULATIONAHA.107.703959","article-title":"Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements","volume":"116","author":"Meier","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0165","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/BF00580262","article-title":"Effects of heart rate and perfusion pressure on segmental coronary resistances and collateral perfusion","volume":"397","author":"Heusch","year":"1983","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0170","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2010.09.014","article-title":"Vascular pathophysiology in response to increased heart rate","volume":"56","author":"Custodis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0175","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.ATV.0000179598.57819.77","article-title":"Bradycardia stimulates vascular growth during gradual coronary occlusion","volume":"25","author":"Lamping","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00019501-200009000-00004","article-title":"Bradycardia is associated with development of coronary collateral vessels in humans","volume":"11","author":"Patel","year":"2000","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000328648","article-title":"Determinants of preformed collateral vessels in the human heart without coronary artery disease","volume":"118","author":"de Marchi","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0190","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurheartj\/ehr255","article-title":"Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis","volume":"33","author":"Schirmer","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0195","doi-asserted-by":"crossref","first-page":"H590","DOI":"10.1152\/ajpheart.00047.2007","article-title":"Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen","volume":"293","author":"Dedkov","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0200","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/heartjnl-2013-304880","article-title":"The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease","volume":"100","author":"Gloekler","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0205","first-page":"P4758","article-title":"Heart rate and the function of preformed coronary collaterals","volume":"30","author":"Gloekler","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0215","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0220","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ehj.2003.10.010","article-title":"Heart rate reduction during exercise-induced myocardial ischaemia and stunning","volume":"25","author":"Monnet","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM199807163390307","article-title":"Hibernating myocardium","volume":"339","author":"Wijns","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00395-015-0511-8","article-title":"Ivabradine reduces myocardial stunning in patients with exercise-inducible ischaemia","volume":"110","author":"Maranta","year":"2015","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.001_bb0235","doi-asserted-by":"crossref","first-page":"H984","DOI":"10.1152\/ajpheart.01109.2004","article-title":"Myocardial hibernation: a delicate balance","volume":"288","author":"Heusch","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316306763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T13:19:09Z","timestamp":1748870349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316306763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":47,"alternative-id":["S0167527316306763"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.001","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}